Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Critical Care (Intensivists) · KALAMAZOO, MI · NPI 1073956371
Verified facts
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
We did not find matching Open Payments records for this doctor in the selected program year.
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 246 | 76 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 223 | 81 |
| Losartan Potassium | Losartan Potassium | 178 | 63 |
| Metformin Hcl Er | Metformin Hcl | 141 | 45 |
| Pantoprazole Sodium | Pantoprazole Sodium | 141 | 48 |
| Amlodipine Besylate | Amlodipine Besylate | 140 | 44 |
| Levothyroxine Sodium | Levothyroxine Sodium | 137 | 39 |
| Omeprazole | Omeprazole | 133 | 43 |
| Lisinopril | Lisinopril | 128 | 41 |
| Gabapentin | Gabapentin | 104 | 40 |
| Tamsulosin Hcl | Tamsulosin Hcl | 100 | 41 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 92 | 24 |
| Metoprolol Succinate | Metoprolol Succinate | 89 | 29 |
| Eliquis | Apixaban | 81 | 22 |
| Alprazolam | Alprazolam | 76 | 16 |
| Mounjaro | Tirzepatide | 75 | 14 |
| Oxycodone Hcl | Oxycodone Hcl | 73 | 13 |
| Ozempic | Semaglutide | 69 | 13 |
| Pregabalin | Pregabalin | 69 | 14 |
| Sertraline Hcl | Sertraline Hcl | 65 | 22 |
| Baclofen | Baclofen | 63 | 13 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 60 | 27 |
| Fluticasone Propionate | Fluticasone Propionate | 57 | 19 |
| Metoprolol Tartrate | Metoprolol Tartrate | 56 | 21 |
| Escitalopram Oxalate | Escitalopram Oxalate | 55 | 21 |
| Buprenorphine | Buprenorphine | 53 | 11 |
| Celecoxib | Celecoxib | 53 | 17 |
| Duloxetine Hcl | Duloxetine Hcl | 52 | 15 |
| Furosemide | Furosemide | 51 | 21 |
| Metformin Hcl | Metformin Hcl | 51 | 17 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 51 | 16 |
| Fluoxetine Hcl | Fluoxetine Hcl | 50 | 24 |
| Prednisone | Prednisone | 50 | 30 |
| Buprenorphine-Naloxone | Buprenorphine Hcl/Naloxone Hcl | 49 | 12 |
| Ipratropium Bromide | Ipratropium Bromide | 40 | 13 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 40 | 11 |
| Trazodone Hcl | Trazodone Hcl | 39 | 13 |
| Trulicity | Dulaglutide | 39 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 38 | 13 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 38 | suppressed |
| Jardiance | Empagliflozin | 37 | 13 |
| Ropinirole Hcl | Ropinirole Hcl | 36 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 35 | 11 |
| Potassium Chloride | Potassium Chloride | 34 | 12 |
| Entresto | Sacubitril/Valsartan | 33 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 33 | suppressed |
| Finasteride | Finasteride | 32 | 11 |
| Meloxicam | Meloxicam | 32 | 14 |
| Clonazepam | Clonazepam | 30 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 30 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 30 | 12 |
| Spironolactone | Spironolactone | 29 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 28 | suppressed |
| Carvedilol | Carvedilol | 27 | 11 |
| Alendronate Sodium | Alendronate Sodium | 25 | suppressed |
| Bupropion Xl | Bupropion Hcl | 25 | 14 |
| Famotidine | Famotidine | 25 | 15 |
| Azithromycin | Azithromycin | 24 | 19 |
| Farxiga | Dapagliflozin Propanediol | 24 | suppressed |
| Linzess | Linaclotide | 24 | suppressed |
| Naproxen | Naproxen | 23 | suppressed |
| Simvastatin | Simvastatin | 23 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 22 | suppressed |
| Chlorthalidone | Chlorthalidone | 22 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 22 | 19 |
| Warfarin Sodium | Warfarin Sodium | 22 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 21 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 21 | suppressed |
| Teriparatide | Teriparatide | 21 | suppressed |
| Buprenorphine Hcl | Buprenorphine Hcl | 20 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 20 | 11 |
| Allopurinol | Allopurinol | 19 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 19 | suppressed |
| Ezetimibe | Ezetimibe | 19 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 19 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 19 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 19 | 11 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 18 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 18 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 17 | 14 |
| Glipizide Er | Glipizide | 17 | suppressed |
| Olanzapine | Olanzapine | 17 | suppressed |
| Ondansetron Odt | Ondansetron | 17 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 17 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 16 | suppressed |
| Ketoconazole | Ketoconazole | 16 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 16 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 16 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 16 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 15 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 15 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 14 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 14 | suppressed |
| Methocarbamol | Methocarbamol | 14 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 14 | suppressed |
| Synthroid | Levothyroxine Sodium | 14 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 14 | suppressed |
| Topiramate | Topiramate | 14 | suppressed |
| Valsartan | Valsartan | 14 | suppressed |
| Ibuprofen | Ibuprofen | 13 | suppressed |
| Novolog Flexpen | Insulin Aspart | 13 | suppressed |
| Primidone | Primidone | 13 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 13 | suppressed |
| Diazepam | Diazepam | 12 | suppressed |
| Estradiol | Estradiol | 12 | suppressed |
| Febuxostat | Febuxostat | 12 | suppressed |
| Fentanyl | Fentanyl | 12 | suppressed |
| Lamotrigine | Lamotrigine | 12 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 12 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 12 | suppressed |
| Torsemide | Torsemide | 12 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 11 | suppressed |
| Atenolol | Atenolol | 11 | suppressed |
| Memantine Hcl | Memantine Hcl | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error